Previous Close | 68.67 |
Open | 69.29 |
Bid | 68.70 x 900 |
Ask | 68.76 x 800 |
Day's Range | 68.34 - 69.06 |
52 Week Range | 63.92 - 88.78 |
Volume | |
Avg. Volume | 785,935 |
Market Cap | 33.497B |
Beta (5Y Monthly) | 0.66 |
PE Ratio (TTM) | 75.11 |
EPS (TTM) | 0.91 |
Earnings Date | N/A |
Forward Dividend & Yield | 0.21 (0.30%) |
Ex-Dividend Date | May 03, 2022 |
1y Target Est | 85.83 |
Alcon's (ALC) robust innovation pipeline is delivering solid results as evidenced by the successful launch of new ATIOL roles and SiHy contact lenses.
GENEVA, August 09, 2022--Alcon Reports Second Quarter 2022 Results
Robust retail and pharmacy sales performance are likely to have driven CVS Health's (CVS) Q2 performance.